These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37921162)
1. Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Segovia F; Garcia H; Alkhateeb H; Mukherjee D; Nickel N Cardiovasc Hematol Disord Drug Targets; 2023; 23(4):215-225. PubMed ID: 37921162 [TBL] [Abstract][Full Text] [Related]
2. Left ventricular heart failure and pulmonary hypertension. Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management. Ltaief Z; Yerly P; Liaudet L Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373119 [TBL] [Abstract][Full Text] [Related]
4. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Dixon DD; Trivedi A; Shah SJ Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826 [TBL] [Abstract][Full Text] [Related]
5. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307 [TBL] [Abstract][Full Text] [Related]
6. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension. Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction. Moles VM; Grafton G Cardiol Clin; 2022 Nov; 40(4):533-540. PubMed ID: 36210136 [TBL] [Abstract][Full Text] [Related]
8. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload. van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Combined Post- and Precapillay Pulmonary Hypertension. Huis In't Veld AE; Oosterveer FPT; De Man FS; Marcus JT; Nossent EJ; Boonstra A; Van Rossum ACB; Vonk Noordegraaf A; Bogaard HJ; Handoko ML J Card Fail; 2020 Jan; 26(1):26-34. PubMed ID: 31394199 [TBL] [Abstract][Full Text] [Related]
10. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction. Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension associated with left heart disease. Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review. Kido K; Coons JC Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390 [TBL] [Abstract][Full Text] [Related]
13. Update in approaches to pulmonary hypertension because of left heart disease. Kennedy JLW; Mihalek AD Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362 [TBL] [Abstract][Full Text] [Related]
14. Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction. Kozaily E; Akdogan ER; Dorsey NS; Tedford RJ Curr Hypertens Rep; 2024 Jul; 26(7):291-306. PubMed ID: 38558124 [TBL] [Abstract][Full Text] [Related]
15. Management of Pulmonary Hypertension in Left Heart Disease. Macera F; Vachiéry JL Methodist Debakey Cardiovasc J; 2021; 17(2):115-123. PubMed ID: 34326931 [TBL] [Abstract][Full Text] [Related]
16. Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction. Meng Q; Lai YC; Kelly NJ; Bueno M; Baust JJ; Bachman TN; Goncharov D; Vanderpool RR; Radder JE; Hu J; Goncharova E; Morris AM; Mora AL; Shapiro SD; Gladwin MT Am J Respir Cell Mol Biol; 2017 Apr; 56(4):497-505. PubMed ID: 28118022 [TBL] [Abstract][Full Text] [Related]
17. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease. Gorter TM; Obokata M; Reddy YNV; Melenovsky V; Borlaug BA Eur Heart J; 2018 Aug; 39(30):2825-2835. PubMed ID: 29947750 [TBL] [Abstract][Full Text] [Related]
18. Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF. Barilli M; Tavera MC; Valente S; Palazzuoli A Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562945 [TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction. Simon MA; Vanderpool RR; Nouraie M; Bachman TN; White PM; Sugahara M; Gorcsan J; Parsley EL; Gladwin MT JCI Insight; 2016 Nov; 1(18):e89620. PubMed ID: 27812547 [TBL] [Abstract][Full Text] [Related]